Alnylam Pharmaceuticals, Inc. (ALNY)
297.45
-3.06
(-1.02%)
USD |
NASDAQ |
May 22, 16:00
297.45
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Assets (Quarterly) : 5.130B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | 66.48M |
| Ionis Pharmaceuticals, Inc. | 3.450B |
| Sarepta Therapeutics, Inc. | 3.179B |
| BridgeBio Pharma, Inc. | 1.371B |
| BioMarin Pharmaceutical, Inc. | 8.591B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.054B |
| Shareholders Equity (Quarterly) | 1.075B |
| Debt to Equity Ratio | 2.762 |
| Current Ratio | 3.127 |
| Net Debt Paydown Yield | -0.10% |